{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:25:23Z","timestamp":1794493523379,"version":"4.9.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Internal Medicine at Yale School of Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe COVID-19. However, the immune signatures associated with immunopathology are poorly understood. Here we use multi-omics single-cell analysis to probe the dynamic immune responses in hospitalized patients with stable or progressive course of COVID-19, explore V(D)J repertoires, and assess the cellular effects of tocilizumab. Coordinated profiling of gene expression and cell lineage protein markers shows that S100A\n                    <jats:sup>hi<\/jats:sup>\n                    \/HLA-DR\n                    <jats:sup>lo<\/jats:sup>\n                    classical monocytes and activated LAG-3\n                    <jats:sup>hi<\/jats:sup>\n                    T cells are hallmarks of progressive disease and highlights the abnormal MHC-II\/LAG-3 interaction on myeloid and T cells, respectively. We also find skewed T cell receptor repertories in expanded effector CD8\n                    <jats:sup>+<\/jats:sup>\n                    clones, unmutated IGHG\n                    <jats:sup>+<\/jats:sup>\n                    B cell clones, and mutated B cell clones with stable somatic hypermutation frequency over time. In conclusion, our in-depth immune profiling reveals dyssynchrony of the innate and adaptive immune interaction in progressive COVID-19.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-27716-4","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T06:02:41Z","timestamp":1642744961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0965-3326","authenticated-orcid":false,"given":"Avraham","family":"Unterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-2642","authenticated-orcid":false,"given":"Tomokazu S.","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-5717","authenticated-orcid":false,"given":"Nima","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-305X","authenticated-orcid":false,"given":"Victor","family":"Gasque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7714-8076","authenticated-orcid":false,"given":"Jonas C.","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Asashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos","family":"Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1441-6122","authenticated-orcid":false,"given":"Micha Sam Brickman","family":"Raredon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-4307","authenticated-orcid":false,"given":"Kenneth B.","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-3687","authenticated-orcid":false,"given":"Zuoheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-8156","authenticated-orcid":false,"given":"Giuseppe","family":"DeIuliis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5558-3758","authenticated-orcid":false,"given":"Neal G.","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3040-9029","authenticated-orcid":false,"given":"Lokesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3301-6143","authenticated-orcid":false,"given":"Arnau","family":"Casanovas-Massana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-6480","authenticated-orcid":false,"given":"Chantal B. F.","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-0279","authenticated-orcid":false,"given":"Anne L.","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Grubaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Melillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0335-5897","authenticated-orcid":false,"given":"Yan","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksym","family":"Minasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasis","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5828-6425","authenticated-orcid":false,"given":"William E.","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inessa","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadir","family":"Raddassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Yale IMPACT Research Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rainone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Niklason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-2339","authenticated-orcid":false,"given":"Albert I.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-4454","authenticated-orcid":false,"given":"Ruth R.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7230-1409","authenticated-orcid":false,"given":"Shelli F.","family":"Farhadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-9856","authenticated-orcid":false,"given":"Akiko","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-9925","authenticated-orcid":false,"given":"David","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-9607","authenticated-orcid":false,"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-1544","authenticated-orcid":false,"given":"Steven H.","family":"Kleinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-535X","authenticated-orcid":false,"given":"David A.","family":"Hafler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5917-4601","authenticated-orcid":false,"given":"Naftali","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-1797","authenticated-orcid":false,"given":"Charles S.","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"27716_CR1","unstructured":"WHO. WHO Coronavirus Disease (COVID-19) Dashboard (2021)."},{"key":"27716_CR2","doi-asserted-by":"crossref","unstructured":"Berlin, D. A., Gulick, R. M. & Martinez, F. J. Severe covid-19. N. Engl. J. Med. 383, 2451\u20132460 (2020).","DOI":"10.1056\/NEJMcp2009575"},{"key":"27716_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395, 1763\u20131770 (2020).","journal-title":"Lancet"},{"key":"27716_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"27716_CR5","doi-asserted-by":"crossref","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature helps predict COVID-19 severity and death. Nat. Med. 26, 1636\u20131643 (2020).","DOI":"10.1038\/s41591-020-1051-9"},{"key":"27716_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijid.2020.04.061","volume":"95","author":"TP Velavan","year":"2020","unstructured":"Velavan, T. P. & Meyer, C. G. Mild versus severe COVID-19: laboratory markers. Int. J. Infect. Dis. 95, 304\u2013307 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"27716_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"27716_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"27716_CR9","doi-asserted-by":"crossref","unstructured":"Price, C. C. et al. Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes. Chest 158, 1397\u20131408 (2020).","DOI":"10.1016\/j.chest.2020.06.006"},{"key":"27716_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret, N. et al. Immunology of COVID-19: current state of the science. Immunity 52, 910\u2013941 (2020).","journal-title":"Immunity"},{"key":"27716_CR11","doi-asserted-by":"crossref","unstructured":"Investigators, R.-C. et al. Interleukin-6 receptor antagonists in critically ill patients with covid-19. N. Engl. J. Med. 384, 1491\u20131502 (2021).","DOI":"10.1056\/NEJMoa2100433"},{"key":"27716_CR12","doi-asserted-by":"crossref","unstructured":"Lombardi, A. et al. Early phases of COVID-19 are characterized by a reduction of lymphocyte populations and the presence of atypical monocytes. Front. Immunol. 11, 560330 (2020).","DOI":"10.3389\/fimmu.2020.560330"},{"key":"27716_CR13","doi-asserted-by":"crossref","unstructured":"Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419\u20131440 (2020).","DOI":"10.1016\/j.cell.2020.08.001"},{"key":"27716_CR14","doi-asserted-by":"crossref","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response to severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","DOI":"10.1038\/s41591-020-0944-y"},{"key":"27716_CR15","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.celrep.2021.109793","volume":"37","author":"N Liu","year":"2021","unstructured":"Liu, N. et al. Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. Cell Rep. 37, 109793 (2021).","journal-title":"Cell Rep."},{"key":"27716_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"27716_CR17","doi-asserted-by":"publisher","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams, T. S. et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci. Adv. 6, eaba1983 (2020).","journal-title":"Sci. Adv."},{"key":"27716_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"27716_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e278 (2020).","journal-title":"Cell"},{"key":"27716_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"27716_CR21","doi-asserted-by":"crossref","unstructured":"Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. 218, e20210582 (2021).","DOI":"10.1101\/2020.12.18.423363"},{"key":"27716_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41392-021-00526-2","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Dynamic blood single-cell immune responses in patients with COVID-19. Signal Transduct. Target Ther. 6, 110 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"27716_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"JY Zhang","year":"2020","unstructured":"Zhang, J. Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107\u20131118 (2020).","journal-title":"Nat. Immunol."},{"key":"27716_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","volume":"42","author":"DMW Zaiss","year":"2015","unstructured":"Zaiss, D. M. W., Gause, W. C., Osborne, L. C. & Artis, D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 42, 216\u2013226 (2015).","journal-title":"Immunity"},{"key":"27716_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/cea.12612","volume":"46","author":"TH Acciani","year":"2016","unstructured":"Acciani, T. H., Suzuki, T., Trapnell, B. C., & Le Cras, T. D. Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease. Clin. Exp. Allergy 46, 317\u2013328 (2016).","journal-title":"Clin. Exp. Allergy"},{"key":"27716_CR26","doi-asserted-by":"crossref","unstructured":"Venkataraman, T., Coleman, C. M. & Frieman, M. B. Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection. J. Virol. 91, e00182-17 (2017).","DOI":"10.1128\/JVI.00182-17"},{"key":"27716_CR27","doi-asserted-by":"publisher","first-page":"e1001304","DOI":"10.1371\/journal.ppat.1001304","volume":"7","author":"SU Seo","year":"2011","unstructured":"Seo, S. U. et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 7, e1001304 (2011).","journal-title":"PLoS Pathog."},{"key":"27716_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","volume":"9","author":"Y Xiong","year":"2020","unstructured":"Xiong, Y. et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microbes Infect. 9, 761\u2013770 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"27716_CR29","doi-asserted-by":"publisher","first-page":"eaaw3851","DOI":"10.1126\/sciadv.aaw3851","volume":"5","author":"MSB Raredon","year":"2019","unstructured":"Raredon, M. S. B. et al. Single-cell connectomic analysis of adult mammalian lungs. Sci. Adv. 5, eaaw3851 (2019).","journal-title":"Sci. Adv."},{"key":"27716_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"27716_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 9, 1123\u20131130 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"27716_CR32","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","volume":"193","author":"FW McNab","year":"2014","unstructured":"McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages. J. Immunol. 193, 3600\u20133612 (2014).","journal-title":"J. Immunol."},{"key":"27716_CR33","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/eji.201646548","volume":"46","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Type I IFN signaling facilitates the development of IL-10-producing effector CD8(+) T cells during murine influenza virus infection. Eur. J. Immunol. 46, 2778\u20132788 (2016).","journal-title":"Eur. J. Immunol."},{"key":"27716_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coi.2016.03.003","volume":"40","author":"KS Forsyth","year":"2016","unstructured":"Forsyth, K. S. & Eisenlohr, L. C. Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation. Curr. Opin. Immunol. 40, 123\u2013129 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"27716_CR35","doi-asserted-by":"publisher","first-page":"e0183594","DOI":"10.1371\/journal.pone.0183594","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS ONE 12, e0183594 (2017).","journal-title":"PLoS ONE"},{"key":"27716_CR36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fimmu.2018.01012","volume":"9","author":"L Lu","year":"2018","unstructured":"Lu, L., Li, J., Moussaoui, M. & Boix, E. Immune modulation by human secreted rnases at the extracellular space. Front. Immunol. 9, 1012 (2018).","journal-title":"Front. Immunol."},{"key":"27716_CR37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3389\/fimmu.2019.01594","volume":"10","author":"IM Yasinska","year":"2019","unstructured":"Yasinska, I. M. et al. The Tim-3-Galectin-9 pathway and its regulatory mechanisms in human breast cancer. Front. Immunol. 10, 1594 (2019).","journal-title":"Front. Immunol."},{"key":"27716_CR38","doi-asserted-by":"publisher","first-page":"e1195535","DOI":"10.1080\/2162402X.2016.1195535","volume":"5","author":"I Goncalves Silva","year":"2016","unstructured":"Goncalves Silva, I. et al. The immune receptor Tim-3 acts as a trafficker in a Tim-3\/galectin-9 autocrine loop in human myeloid leukemia cells. Oncoimmunology 5, e1195535 (2016).","journal-title":"Oncoimmunology"},{"key":"27716_CR39","doi-asserted-by":"crossref","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).","DOI":"10.1126\/sciimmunol.abd1554"},{"key":"27716_CR40","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e1819 (2021).","journal-title":"Cell"},{"key":"27716_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2172-6-2","volume":"6","author":"R Reghunathan","year":"2005","unstructured":"Reghunathan, R. et al. Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol. 6, 2 (2005).","journal-title":"BMC Immunol."},{"key":"27716_CR42","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","volume":"136","author":"F Zhao","year":"2012","unstructured":"Zhao, F. et al. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 136, 176\u2013183 (2012).","journal-title":"Immunology"},{"key":"27716_CR43","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Calcium-binding proteins S100A8 and S100A9: investigation of their immune regulatory effect in myeloid cells. Int. J. Mol. Sci. 19, 1833 (2018).","DOI":"10.3390\/ijms19071833"},{"key":"27716_CR44","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3389\/fimmu.2019.02243","volume":"10","author":"M Huang","year":"2019","unstructured":"Huang, M. et al. S100A9 regulates MDSCs-mediated immune suppression via the RAGE and TLR4 signaling pathways in colorectal carcinoma. Front. Immunol. 10, 2243 (2019).","journal-title":"Front. Immunol."},{"key":"27716_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40285-3","volume":"9","author":"MR Goulart","year":"2019","unstructured":"Goulart, M. R. et al. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells. Sci. Rep. 9, 3574 (2019).","journal-title":"Sci. Rep."},{"key":"27716_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes, M. et al. An immune-cell signature of bacterial sepsis. Nat. Med. 26, 333\u2013340 (2020).","journal-title":"Nat. Med."},{"key":"27716_CR47","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27, 992\u20131000.e1003 (2020).","journal-title":"Cell Host Microbe"},{"key":"27716_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MOP.0000000000000352","volume":"28","author":"JA Muszynski","year":"2016","unstructured":"Muszynski, J. A., Thakkar, R. & Hall, M. W. Inflammation and innate immune function in critical illness. Curr. Opin. Pediatr. 28, 267\u2013273 (2016).","journal-title":"Curr. Opin. Pediatr."},{"key":"27716_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/art.38324","volume":"66","author":"Y Saito","year":"2014","unstructured":"Saito, Y. et al. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor gammat-induced Th17 cell differentiation. Arthritis Rheumatol. 66, 1185\u20131194 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"27716_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2018.07.003","volume":"332","author":"I Bah","year":"2018","unstructured":"Bah, I., Kumbhare, A., Nguyen, L., McCall, C. E. & El Gazzar, M. IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development. Cell Immunol. 332, 32\u201338 (2018).","journal-title":"Cell Immunol."},{"key":"27716_CR51","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1101\/gad.262642.115","volume":"29","author":"R Rodriguez-Barrueco","year":"2015","unstructured":"Rodriguez-Barrueco, R. et al. Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-\/HER2+ breast cancers. Genes Dev. 29, 1631\u20131648 (2015).","journal-title":"Genes Dev."},{"key":"27716_CR52","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. S100A8\/A9 in inflammation. Front. Immunol. 9, 1298 (2018).","journal-title":"Front. Immunol."},{"key":"27716_CR53","doi-asserted-by":"crossref","unstructured":"Shi, H. et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. J. Leukoc. Biol. 109, 67\u201372 (2021).","DOI":"10.1002\/JLB.3COVCRA0720-359R"},{"key":"27716_CR54","doi-asserted-by":"crossref","unstructured":"Chen, L. et al. Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol. Immunol. 17, 992\u2013994 (2020).","DOI":"10.1038\/s41423-020-0492-x"},{"key":"27716_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0356-0","volume":"17","author":"H Reeh","year":"2019","unstructured":"Reeh, H. et al. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor alpha to gp130 expression: fusing experimental insights and dynamic modelling. Cell Commun. Signal 17, 46 (2019).","journal-title":"Cell Commun. Signal"},{"key":"27716_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","volume":"43","author":"ZM Ndhlovu","year":"2015","unstructured":"Ndhlovu, Z. M. et al. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 43, 591\u2013604 (2015).","journal-title":"Immunity"},{"key":"27716_CR57","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1128\/JVI.74.18.8413-8424.2000","volume":"74","author":"A Kaur","year":"2000","unstructured":"Kaur, A., Hale, C. L., Ramanujan, S., Jain, R. K. & Johnson, R. P. Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J. Virol. 74, 8413\u20138424 (2000).","journal-title":"J. Virol."},{"key":"27716_CR58","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1128\/JVI.05548-11","volume":"85","author":"T Lindgren","year":"2011","unstructured":"Lindgren, T. et al. Longitudinal analysis of the human T cell response during acute hantavirus infection. J. Virol. 85, 10252\u201310260 (2011).","journal-title":"J. Virol."},{"key":"27716_CR59","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.4049\/jimmunol.181.8.5551","volume":"181","author":"J Heidema","year":"2008","unstructured":"Heidema, J. et al. Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold. J. Immunol. 181, 5551\u20135559 (2008).","journal-title":"J. Immunol."},{"key":"27716_CR60","doi-asserted-by":"crossref","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, eabc8511 (2020).","DOI":"10.1126\/science.369.6508.1203-l"},{"key":"27716_CR61","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"27716_CR62","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson, A. C., Joller, N. & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity 44, 989\u20131004 (2016).","journal-title":"Immunity"},{"key":"27716_CR63","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"27716_CR64","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci. Immunol. 1, eaai8593 (2016).","DOI":"10.1126\/sciimmunol.aai8593"},{"key":"27716_CR65","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"27716_CR66","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","volume":"558","author":"N Chihara","year":"2018","unstructured":"Chihara, N. et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558, 454\u2013459 (2018).","journal-title":"Nature"},{"key":"27716_CR67","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168.e114 (2020).","journal-title":"Cell"},{"key":"27716_CR68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/eji.201545765","volume":"46","author":"N Honke","year":"2016","unstructured":"Honke, N. et al. Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses. Eur. J. Immunol. 46, 372\u2013380 (2016).","journal-title":"Eur. J. Immunol."},{"key":"27716_CR69","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","volume":"38","author":"LM Snell","year":"2017","unstructured":"Snell, L. M., McGaha, T. L. & Brooks, D. G. Type I interferon in chronic virus infection and cancer. Trends Immunol. 38, 542\u2013557 (2017).","journal-title":"Trends Immunol."},{"key":"27716_CR70","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","volume":"31","author":"NT Gupta","year":"2015","unstructured":"Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356\u20133358 (2015).","journal-title":"Bioinformatics"},{"key":"27716_CR71","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495.e1420 (2020).","journal-title":"Cell"},{"key":"27716_CR72","doi-asserted-by":"crossref","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","DOI":"10.1038\/s41587-020-0505-4"},{"key":"27716_CR73","doi-asserted-by":"publisher","first-page":"701085","DOI":"10.3389\/fimmu.2021.701085","volume":"12","author":"F Bieberich","year":"2021","unstructured":"Bieberich, F. et al. A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients. Front. Immunol. 12, 701085 (2021).","journal-title":"Front. Immunol."},{"key":"27716_CR74","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.immuni.2020.06.024","volume":"53","author":"C Schultheiss","year":"2020","unstructured":"Schultheiss, C. et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity 53, 442\u2013455.e444 (2020).","journal-title":"Immunity"},{"key":"27716_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/srep20842","volume":"6","author":"Y Avnir","year":"2016","unstructured":"Avnir, Y. et al. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity. Sci. Rep. 6, 20842 (2016).","journal-title":"Sci. Rep."},{"key":"27716_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","volume":"34","author":"F Chen","year":"2019","unstructured":"Chen, F., Tzarum, N., Wilson, I. A. & Law, M. VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design. Curr. Opin. Virol. 34, 149\u2013159 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"27716_CR77","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.chom.2020.09.002","volume":"28","author":"SCA Nielsen","year":"2020","unstructured":"Nielsen, S. C. A. et al. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2. Cell Host Microbe 28, 516\u2013525 e515 (2020).","journal-title":"Cell Host Microbe"},{"key":"27716_CR78","doi-asserted-by":"crossref","unstructured":"Hoehn, K. B. et al. Cutting edge: distinct B cell repertoires characterize patients with mild and severe COVID-19. J. Immunol. 206, 2785\u20132790 (2021).","DOI":"10.4049\/jimmunol.2100135"},{"key":"27716_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko, N. et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell 183, 143\u2013157.e113 (2020).","journal-title":"Cell"},{"key":"27716_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen, W. et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 6, 31 (2020).","journal-title":"Cell Discov."},{"key":"27716_CR81","doi-asserted-by":"crossref","unstructured":"Guo, C. et al. Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis. Nat. Commun. 11, 3924 (2020).","DOI":"10.1038\/s41467-020-17834-w"},{"key":"27716_CR82","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl. Sci. Rev. 7, 998\u20131002 (2020).","DOI":"10.1093\/nsr\/nwaa041"},{"key":"27716_CR83","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","volume":"43","author":"S Koyama","year":"2008","unstructured":"Koyama, S., Ishii, K. J., Coban, C. & Akira, S. Innate immune response to viral infection. Cytokine 43, 336\u2013341 (2008).","journal-title":"Cytokine"},{"key":"27716_CR84","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199\u20131207 (2020).","journal-title":"N. Engl. J. Med."},{"key":"27716_CR85","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 20, 656\u2013657 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"27716_CR86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"27716_CR87","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion\u2019. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"27716_CR88","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.4049\/jimmunol.1403004","volume":"195","author":"JJ Erickson","year":"2015","unstructured":"Erickson, J. J. et al. Acute viral respiratory infection rapidly induces a CD8+ T cell exhaustion-like phenotype. J. Immunol. 195, 4319\u20134330 (2015).","journal-title":"J. Immunol."},{"key":"27716_CR89","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208\u2013220 (2016).","journal-title":"Trends Immunol."},{"key":"27716_CR90","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.1701019","volume":"200","author":"S Ostrand-Rosenberg","year":"2018","unstructured":"Ostrand-Rosenberg, S. & Fenselau, C. Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J. Immunol. 200, 422\u2013431 (2018).","journal-title":"J. Immunol."},{"key":"27716_CR91","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","volume":"12","author":"DG Brooks","year":"2006","unstructured":"Brooks, D. G. et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12, 1301\u20131309 (2006).","journal-title":"Nat. Med."},{"key":"27716_CR92","doi-asserted-by":"publisher","first-page":"6104054","DOI":"10.1155\/2017\/6104054","volume":"2017","author":"JM Rojas","year":"2017","unstructured":"Rojas, J. M., Avia, M., Martin, V. & Sevilla, N. IL-10: a multifunctional cytokine in viral infections. J. Immunol. Res. 2017, 6104054 (2017).","journal-title":"J. Immunol. Res."},{"key":"27716_CR93","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","volume":"6","author":"TT Braga","year":"2015","unstructured":"Braga, T. T., Agudelo, J. S. & Camara, N. O. Macrophages during the fibrotic process: M2 as friend and foe. Front. Immunol. 6, 602 (2015).","journal-title":"Front. Immunol."},{"key":"27716_CR94","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028\u20131040 (2012).","journal-title":"Nat. Med."},{"key":"27716_CR95","doi-asserted-by":"publisher","first-page":"e1004103","DOI":"10.1371\/journal.ppat.1004103","volume":"10","author":"Y Avnir","year":"2014","unstructured":"Avnir, Y. et al. Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS Pathog. 10, e1004103 (2014).","journal-title":"PLoS Pathog."},{"key":"27716_CR96","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0169-5347(03)00216-7","volume":"18","author":"AJ Drummond","year":"2003","unstructured":"Drummond, A. J., Pybus, O. G., Rambaut, A., Forsberg, R. & Rodrigo, A. G. Measurably evolving populations. Trends Ecol. Evol. 18, 481\u2013488 (2003).","journal-title":"Trends Ecol. Evol."},{"key":"27716_CR97","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2020","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106.e111 (2020).","journal-title":"Cell"},{"key":"27716_CR98","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4049\/jimmunol.1301384","volume":"192","author":"C Wang","year":"2014","unstructured":"Wang, C. et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J. Immunol. 192, 603\u2013611 (2014).","journal-title":"J. Immunol."},{"key":"27716_CR99","doi-asserted-by":"crossref","unstructured":"Kreer, C. et al. Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients. Cell 182, 843\u2013854.e12 (2020).","DOI":"10.1016\/j.cell.2020.06.044"},{"key":"27716_CR100","doi-asserted-by":"crossref","unstructured":"Mudd, P. A. et al. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci. Adv. 6, eabe3024 (2020).","DOI":"10.1126\/sciadv.abe3024"},{"key":"27716_CR101","unstructured":"Wyllie, A. L. et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N. Engl. J. Med. 383, 1283\u20131286 (2020)."},{"key":"27716_CR102","unstructured":"Vogels, C. B. F. et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets. Nat. Microbiol. 5, 1299\u20131305 (2020)."},{"key":"27716_CR103","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"27716_CR104","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 e1821 (2019).","journal-title":"Cell"},{"key":"27716_CR105","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"27716_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"27716_CR107","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"27716_CR108","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27716_CR109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"27716_CR110","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."},{"key":"27716_CR111","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"27716_CR112","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"27716_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24198-1","volume":"8","author":"YM El-Sherbiny","year":"2018","unstructured":"El-Sherbiny, Y. M. et al. A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Sci. Rep. 8, 5793 (2018).","journal-title":"Sci. Rep."},{"key":"27716_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"27716_CR115","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature22976","volume":"547","author":"J Glanville","year":"2017","unstructured":"Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94\u201398 (2017).","journal-title":"Nature"},{"key":"27716_CR116","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.4049\/jimmunol.1601850","volume":"198","author":"NT Gupta","year":"2017","unstructured":"Gupta, N. T. et al. Hierarchical clustering can identify B cell clones with high confidence in Ig repertoire sequencing data. J. Immunol. 198, 2489\u20132499 (2017).","journal-title":"J. Immunol."},{"key":"27716_CR117","doi-asserted-by":"publisher","first-page":"22664","DOI":"10.1073\/pnas.1906020116","volume":"116","author":"KB Hoehn","year":"2019","unstructured":"Hoehn, K. B. et al. Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination. Proc. Natl Acad. Sci. USA 116, 22664\u201322672 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27716_CR118","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/genetics\/148.3.929","volume":"148","author":"R Nielsen","year":"1998","unstructured":"Nielsen, R. & Yang, Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148, 929\u2013936 (1998).","journal-title":"Genetics"},{"key":"27716_CR119","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/molbev\/msy194","volume":"35","author":"G Yu","year":"2018","unstructured":"Yu, G., Lam, T. T., Zhu, H. & Guan, Y. Two methods for mapping and visualizing associated data on phylogeny using Ggtree. Mol. Biol. Evol. 35, 3041\u20133043 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"27716_CR120","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/2041-210X.12466","volume":"7","author":"GG Murray","year":"2016","unstructured":"Murray, G. G. et al. The effect of genetic structure on molecular dating and tests for temporal signal. Methods Ecol. Evol. 7, 80\u201389 (2016).","journal-title":"Methods Ecol. Evol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27716-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27716-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:52:49Z","timestamp":1669287169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27716-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27716"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27716-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.16.20153437","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"28 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.H.K. receives consulting fees from Northrop Grumman. L.E.N. is a founder and shareholder in Humacyte, Inc, which is a regenerative medicine company. Humacyte produces engineered blood vessels from allogeneic smooth muscle cells for vascular surgery. L.E.N.\u2019s spouse has equity in Humacyte, and L.E.N. serves on Humacyte\u2019s Board of Directors. L.E.N. is an inventor on patents that are licensed to Humacyte and that produce royalties for L.E.N. L.E.N. has received an unrestricted research gift to support research in her laboratory at Yale. Humacyte did not fund these studies, and Humacyte did not influence the conduct, description, or interpretation of the findings in this report. N.D.G. is a paid consultant for Tempus Labs and the National Basketball Association. A.I.K. received consulting fees from Tata Sons and Regeneron and is a recipient of grants on COVID-19 from Merck, Regeneron, and Serimmune all of which are outside the submitted work. K.B.H. receives consulting fees from Prellis Biologics. C.D.C. is a recipient of a grant from BMS. A.U. reports personal consulting fees from Boehringer Ingelheim, RemedyCell, Augmanity Nano, and 1E Therapeutics in the last 36 months, and Equity in RemedyCell, all outside the submitted work. D.A.H. has received research funding from Bristol-Myers Squibb, Novartis, Sanofi, and Genentech. He has been a consultant for Bayer Pharmaceuticals, Bristol Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno Therapeutics, Novartis Pharmaceuticals, Proclara Biosciences, Sage Therapeutics, and Sanofi Genzyme. Further information regarding funding is available on:\n                      \n                      . N.K. reports personal fees from Boehringer Ingelheim, Third Rock, Pliant, Samumed, NuMedii, Indalo, Theravance, LifeMax, Three Lake Partners, RohBar, Astra Zeneca, Veracyte, Augmanity, CSL Behring, and Thyron in the last 36 months, and reports equity in Pliant and Thyron. N.K. is also a recipient of a grant from Veracyte Boehringer Ingelheim, BMS, and non-financial support from MiRagen and Astra Zeneca. All outside the submitted work; in addition, N.K. has patents on New Therapies in Pulmonary Fibrosis and ARDS (optioned to biotech) and Peripheral Blood Gene Expression as biomarkers in IPF (licensed to biotech). T.S.S., N.N., X.Y., A.Y.Z., V.G., J.C.S., H.A., Y.L., C.C.Jr., W.D., M.C., M.S.B.R., G.W., Z.W., G.D., N.G.R., N.L., C.C., P.W., J.F., S.B., L.S., A.C., C.B.F.V., A.L.W., A.M., H.M., Y.S., M.M., S.M., W.E.R, I.C., K.R., R.R.M., S.F.F., A.I., A.C.S., D.V.D., and H.Z. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"440"}}